IPPI 2026 Spring Progress Report (December 2025- February 2026) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive Director Joshua Kresh We’ve had both a productive end to 2025 and start to 2026. IPPI hosted our final meeting of the 2025-2026 Edison Fellowship […]
IPPI 2025 Winter Progress Report (September – November 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive Director Joshua Kresh We have had a busy fall and have no plans on slowing down next year. November brought our inaugural roundtable on Intellectual […]
By Kristen Osenga Cross-posted with permission from Professor Osenga’s December 8, 2025, LinkedIn article I’ve seen a lot of misinformation circulating online lately about patents and their role in drug prices. Some articles – like this one – claim that so-called “patent thickets” are an abusive strategy drug companies use to keep prices high. The […]
IPPI Fall 2025 Progress Report (June – August 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive Director Joshua Kresh I am happy to report a productive summer quarter marked by significant milestones and successful new initiatives that have strengthened our institute’s […]
By Michael Doane The CEO of a small technology-based company with many groundbreaking patents in its field once asked me what the point was of obtaining patents when the company simply did not have the resources to enforce them. Although patents provide many benefits, the ability to enforce them against infringers is paramount. Patent infringement […]
IPPI Spring 2025 Progress Report (March – May 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive Director Joshua Kresh We are pleased to present our first comprehensive progress report since IPPI’s launch at The University of Akron on March 1st. Team […]
IPPI has submitted formal comments to the U.S. Department of Commerce regarding its Section 232 investigation of pharmaceutical imports, cautioning against imposing tariffs on medicines and their ingredients. In our submission, IPPI scholars Mark Schultz, Emily Michiko Morris, and Joshua Kresh explain that imposing such tariffs would have severe negative consequences for American patients, healthcare […]
By Kristen Jakobsen Osenga As the 118th Congress drew to a close at the end of 2024, there was a spate of intellectual property activity on Capitol Hill. I was fortunate enough to be part of one of these exciting events. On December 18, 2024, the IP Subcommittee of the Senate Judiciary Committee held a […]
Navigation Announcing IPPI: The IP Policy Institute A Message from Faculty Chair Mark Schultz & Executive Director Joshua Kresh IPPI Spring Progress Report (December 2024-February 2025) IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Announcing IPPI: The IP Policy Institute A Message from Faculty Chair Mark Schultz and Executive Director […]
By Emily Michiko Morris and Joshua Kresh Executive summary: Many critics of pharmaceutical companies argue that they abuse the patent system through “evergreening” or “thickets” to increase the amount of time they can avoid generic competition and keep drug prices high. Those critics have not looked at the real-world effects of pharmaceutical patents on generic […]